The accelerator requirements of particle radiation therapy are reviewed and a preliminary design of a heavy ion synchrotron for hospital installation is presented.
Introduction
A broad future application of particle beams in radiation therapy demands hospital-based accelerators designed for cost-effectiveness, high reliability and modest operations and maintenance crews. We discuss here machines capable of deliverying therapeutic ion beams, protons to neon, emphasizing carbon for purposes of detailed illustration and including the capability of producing neutron beams.
Beam Specifications
Particle species, energy and beam intensity determine the design of the optimal accelerator type. The energy is determined by the required range, the atomic number Z and the mass number A of the beam (Figure 1 ).
Typical ranges for therapy fall between 25 and 32 cm. Radiography requires slightly higher energies than therapy or must be performed with lighter ions. We studied in detail a sector focused, superconducting FM-cyclotron with an internal ion source. Up to approximately 100 MeV/amu an isochronous field would be maintained allowing the production of intense deuteron begims for neutron therapy. At a field level <B> X 4.8T C+ beams are accelerated to %400 MeV/amu. An extraction scheme, based on stripping the beam into c+6 and the use of a magnetic channel, was shown to be essentially 100% effective and to conserve good beam quality. We slightly favor synchrotons in the proposed application for their lower cost and, most important possibly, greater flexibility in terms of available beams and beam energies.
Synchrotron Design and Optimization
A cost-optimized design of a synchrotron providing beams from protons to neon at the initially specified intensities is attempted. Maximum design energy is 415
MeV/amu (Bp = 6.5 Tm for e/m = 0.5, range in tissue \28 cm for carbon). Modest changes in peak energy will not alter the basic design and corresponding incremental costs are indicated in Fig. 2 . For simplicity and reliability mechanical activators, plunqing magnets and MGsets will be absent. The use of cannea magnets is planned.
Injectors
The specifications for an injector are based on a PIG ion source. Obviously a trade-off between magnet aperture and repetition rate is involved in designing a synchrotron for a given average beam intensity. Aperture is determined by space charge for the lighter ions, by injector brightness for the heavier ones. Assuming expected values for 6-functions and stacking efficiencies values of frep were optimized with respect to magnet, magnet power supply and RF-system costs. Optimum values differ for different injector types but all fall in the range from lu Hz to 3 Hz, with 2 Hz being specified for the present design (Fig. 3) .
Synchrotron Lattice
The main goals in designing possible lattice configurations were: to utilize the magnet aperture efficiently by minimizing 6-functions, to facilitate magnet design, construction and alignment by keeping tunes faily low and to obtain a transition energy above the design peak energy. The lowest periodicity meeting these requirements is six. Six periods, each containing a long and short straight section, provide suitable positions for injection, extraction and correction elements as well as an accelerating cavity and diagnostic equipment. Both combined and separated function lattices with the desired properties have been designed.
The combined function lattice, s1milar to the ANL PSB design 2, has the advantage of fewer elements and independent parameters an2 is preferred for this application. 
Operational Aspects
Peak power demand for this facility is estimated to be about 2.7 MW (0.25 for injector, 1.85 synchrotron (peak), 0.6 for one isocentric delivery system). Average consumption is less of course and if the synchrotron and beam lines are powered only during treatments, average power for a 3-treatment room facility is well below 1 MW. A total operations and maintenance staff of at most 10 members is aimed at. A self-diagnosing computer control system is necessary to achi¢:ve this. This aspect is studied and experience from the SuperHILAC/Bevalac system indicates that this is a realistic goal for a medical accelerator in routine operation. 
